Clinicopathologic Characterization of Nasopharyngeal Carcinoma seen in the Radiotherapy and Oncology Department, Ahmadu Bello university Teaching Hospital, Zaria, Nigeria: 2006-2010
Article Sidebar
Views | PDF/EPUB Downloads:
50
/ 6
/ 6
Main Article Content
Abstract
Aims and Objective: To evaluate the clinical and pathological characteristics of nasopharyngeal carcinoma (NPC) patients seen in the Radiotherapy and Oncology department, Ahmadu Bello University Teaching Hospital, Nigeria.
Materials and Methods: Between January 2006 and December 2010, 45 patients with histologically confirmed NPC were seen and evaluated irrespective of age, co-morbidity and performance status. Patients’ folders were reviewed retrospectively with a structured pro forma. Data were analyzed using Epi Info software and results presented in simple tables.
Results: A total of 45 patients had NPC accounting for 2%. The mean age was 42 years (range 15-75 years). The sex ratio was M:F = 2.2:1. 21 of the patients were from North-West geopolitical zone. Hausa-Fulani was the predominant ethnic group in 23 patients. At presentation, 41 had neck mass followed by nasal blockage in 34, cranial nerve deficits in 27 and epistaxis in 25 (55.6%) patients. The commonest cranial nerves affected were vestibulocochlear 17, followed by glossopharyngeal 14. Only 14 patients presented within 12 months of onset of symptoms with a range of 3-60 months. The commonest histologic type seen was WHO-2 (Non-keratinizing Squamous Cell Carcinoma) in 28 patients. Locally advanced disease (IVA and IVB) seen in 25 patients and metastatic disease (IVC) seen in 13 patients. The site of metastases was the bones seen in 6 patients followed by lungs in 5 patients. Only 2 patients were positive for HIV antibodies. 38 patients were treated with chemotherapy and 18 received radiation therapy.
Conclusion: Nasopharyngeal cancer is commoner in males. Neck mass with nasal and auditory symptoms were the commonest symptoms. More than half of the patients had cranial nerve deficits at presentation. WHO-2 is the commonest histology and locally advanced and metastatic disease is the commonest stage at presentation.
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
How to Cite
References
1. Chan J, Bray F, McCarron P, Foo W, Lee AWM, Yip T, et al. Nasopharyngeal carcinoma. In: Barnes L, Eveson JW, Reichart P, Sidransky D (editors). World Health Organization classification of tumours: Pathology and genetics of head and neck tumours. Lyon,
France: IARC Press; 2005. p. 85‑97.
2. Farley J, Bray F, Pisani P, Parkin DM. Globocan 2000: Cancer incidence, mortality and prevalence worldwide. 10th ed. Lyon, France: IARC Press; 2001.
3. Niedobitek G. Epstein‑Barr virus infection in the pathogenesis of nasopharyngeal carcinoma. Mol Pathol 2000;53:248‑54.
4. Neel HB 3 rd, Pearson GR, Weiland LH, Taylor WF, Goepfert HH, Pilch BZ, et al. Application of Epstein‑Barr virus serology to the diagnosis and staging of North American patients with nasopharyngeal carcinoma. Otolaryngol Head Neck Surg 1983;91:255‑62.
5. Lo YM, Chan AT, Chan LY, Leung SF, Lam CW, Huang DP, et al. Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein‑Barr virus DNA. Cancer Res 2000;60:6878‑81.
6. Maier H, Dietz A, Gewelke U, Heller WD, Weidauer H. Tobacco and alcohol and the risk of head and neck cancer. Clin Investig 1992; 70:320‑7.
7. Conley BA, Forastiere AA, Gius D, VanWaes C. Head and Neck Cancer. In: Abraham J, Allegra CJ, Gulley J, editors. Bethesda
Handbook of Clinical Oncology, 2 nd Ed. Lippincott Williams and Wilkins Publishers Philadelphia; 2005. p. 3‑31.
8. Parker RG, Rice DH, Casciato DA. Head and Neck Cancers. In: Casciato DA, Lowitz BB, editors. Manual of Clinical Oncology, 3rd ed. Little, Brown and Company Boston;1995. p. 113‑32.
9. Lee AW, Poon YF, Foo W, Law SC, Cheung FK, Chan DK, et al. Retrospective analysis of 5037 patients with nasopharyngeal
carcinoma treated during 1976‑1985: Overall survival and patterns of failure. Int J Radiat Oncol Biol Phys 1992;23:261‑70.
10. Lee AW, Sze WM, Au JS, Leung SF, Leung TW, Chua DT, et al. Treatment results for nasopharyngeal carcinoma in the modern
era: The Hong Kong experience. Int J Radiat Oncol Biol Phys 2005; 61:1107‑16.
11. Chong VF, Mukherji SK, Ng SH, Ginsberg LE, Wee JT, Sham JS, et al. Nasopharyngeal carcinoma: Review of how imaging affects
staging. J Comput Assist Tomogr 1999;23:984‑93.
12. Quon H. Cancers of the Head and Neck. In: Abeloff MD, Armitage OJ, Niederhuber JE, Kastan BM, McKenna GW, Editors.
Clinical Oncology, 3rd ed. Elsevier Churchill Livingstone Publishers; Philadelphia. 2005. p. 1177‑228.
13. Chao Klifford KS, Perez CA, Brady LW. Nasopharynx. In: Management Decisions, Radiation Oncology. Chao Klifford KS, Perez CA, Brady LW, editors. Philadelphia: Lippincott‑Raven Publishers; 1999. p. 189‑202.
14. Al‑Sarraf M, LeBlanc M, Giri PG, Fu KK, Cooper J, Vuong T, et al. Superiority of chemoradiotherapy (CT‑RT) vs. radiotherapy (RT)
in patients (PTS) with locally advanced nasopharyngeal cancer (NPC): Preliminary results of Intergroup (0099) (SWOG 8892, RTOG 8817, ECOG 2388) randomized study. Proc Am Soc Clin Oncol 1996;15:313.
15. Alabi BS, Badmos KB, Afolabi OA, Buhari MO, Segun‑Busari S. Clinico‑pathological pattern of nasopharyngeal carcinoma in Ilorin,
Nigeria. Niger J Clin Pract 2010;13:445‑8.
16. Obafunwa JO, Bhatia PL. Nasopharyngeal carcinoma in Plateau State, Nigeria: A pathological study. Eur J Surg Oncol 1991;17:335‑7.
17. Iseh KR, Abdullahi A, Malami SA. Clinical and histological characteristics of nasopharyngeal cancer in Sokoto, north‑western,
Nigeria. West Afr J Med 2009;28:151‑5.
18. Abuidris DO, Elgaili EM, Elhaj AH, Elmustafa OM. Histoplathological patterns of nasopharyngeal carcinoma in Sudan. Saudi Med J 2008; 29:962‑5.
19. Marks JE, Phillips JL, Menck HR. The national cancer data base report on the relationship of race and national origin to the
histology of nasopharyngeal carcinoma. Cancer 1998;83:582‑8.
20. Lee AW, Foo W, Mang O, Sze WM, Chappell R, Lau WH, et al. Changing epidemiology of nasopharyngeal carcinoma in Hong
Kong over a 20‑year period (1980‑99): An encouraging reduction in both incidence and mortality. Int J Cancer 2003;20:680‑5.
21. Sham JS, Cheung YK, Choy D, Chan FL, Leong L. Cranial nerve involvement and base of skull erosion in nasopharyngeal
carcinoma. Cancer 1991;68:422‑6.
22. Chan AT, Teo ML, Lee WY, Kwan WH, Choi PH, Johnson PJ. The significance of keratinizing squamous cell histology in Chinese
patients with nasopharyngeal carcinoma. Clin Oncol (R Coll Radiol) 1998;10:161‑4.
23. Taamma A, Fandi A, Azli N, Wibault P, Chouaki N, Hasbini A, et al. Phase II trial of chemotherapy with 5‑fluorouracil, bleomycin,
epirubicin, and cisplatin for patients with locally advanced, metastatic, or recurrent undifferentiated carcinoma of the
nasopharyngeal type. Cancer 1999;86:1101‑8.
24. Kaasa S, Kragh‑Jensen E, Bjordal K, Lund E, Evensen JF, Vermund H, et al. Prognostic factors in patients with nasopharyngeal carcinoma. Acta Oncol 1993;32:531‑6.
25. Adewuyi SA, Arogundade R, Igashi JB, Chom ND, Hamidu AU, Campbell OB. The pattern of chest radiographs findings in metastatic cancer patients seen in a tertiary hospital in northern Nigeria. Niger Postgrad Med J 2011;18:245‑50.
26. Flaitz CM, Nichols CM, Adler‑Storthz K, Hicks MJ. Intraoral squamous cell carcinoma in human immunodeficiency virus infection: A clinicopathologic study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995;80:55‑62.
27. van Zuuren EJ, de Visscher JG, Bouwes Bavinck JN. Carcinoma of the lip in kidney transplant recipients. J Am Acad Dermatol 1998;38:497‑9.
28. Adewuyi SA. Cervical cancer in HIV seropositive patients. Ann Afr Med 2007;6:41‑2.
29. Al‑Sarraf M, LeBlanc M, Giri PG, Fu KK, Cooper J, Vuong T, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099. J Clin Oncol 1998;16:1310‑7.
30. Chan ATC, Teo PML, Leung WT, Johnson PJ. Role of chemotherapy in the management of nasopharyngeal carcinoma. Cancer 1998; 82: 1003‑12.
31. Qin DX, Hu YH, Yan JH, Xu GZ, Cai WM, Wu XL, et al. Analysis of 1379 patients with nasopharyngeal carcinoma treated by radiation. Cancer 1988;61:1117‑24.